EFFECT OF RIFAMPICIN ON THE MOUSE HEPATIC MIXED-FUNCTION OXIDASE SYSTEM

被引：24

作者：

TREDGER, JM

SMITH, HM

POWELLJACKSON, PR

DAVIS, M

WILLIAMS, R

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1981年 / 30卷 / 10期

关键词：

D O I：

10.1016/0006-2952(81)90440-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1043 / 1051

页数：9

共 42 条

[1] CLINICAL PHARMACOKINETICS OF RIFAMPICIN [J].

ACOCELLA, G .

CLINICAL PHARMACOKINETICS, 1978, 3 (02) :108-127

[2]

BEND JR, 1972, J PHARMACOL EXP THER, V183, P206

[3]

BIRNBAUM LS, 1976, RES COMMUN CHEM PATH, V15, P553

[4] EFFECT OF RIFAMPICIN TREATMENT ON METABOLISM OF ESTRADIOL AND 17 ALPHA-ETHINYLESTRADIOL BY HUMAN LIVER-MICROSOMES [J].

BOLT, HM ;

KAPPUS, H ;

BOLT, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (05) :301-307

[5]

BOOBIS AR, 1977, MOL PHARMACOL, V13, P259

[6]

BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470

[7]

BURKE MD, 1977, DRUG METAB DISPOS, V5, P1

[8] RELATIONSHIP BETWEEN INDUCTION OF ARYL-HYDROCARBON HYDROXYLASE AND DENOVO SYNTHESIS OF CYTOCHROME-P-448 (P-1-450) IN MICE [J].

CHHABRA, RS ;

TREDGER, JM ;

PHILPOT, RM ;

FOUTS, JR .

CHEMICO-BIOLOGICAL INTERACTIONS, 1976, 15 (01) :21-31

[9]

CONNEY AH, 1967, PHARMACOL REV, V19, P317

[10]

EDWARDS OM, 1974, LANCET, V2, P549

← 1 2 3 4 5 →